Ivermectin As a COVID-19 Therapy

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Drug Approvals, Health News, Infectious Disease

Table of Contents Introduction: The Controversy Around Ivermectin Ivermectin, a drug primarily used to treat parasitic infections in animals and humans, has found itself at the center of a heated debate regarding its potential as a therapy for COVID-19. In this article, we delve into the conflicting opinions, clinical evidence, and the passionate advocates behind […]

Meta-analysis finds some ivermectin benefits in COVID-19 patient

An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. The study also found that ivermectin was “associated […]

Meta-analysis finds some ivermectin benefits in COVID-19 patient

Categories: Bacteria & Viruses, coronavirus, COVID-19, Drug Approvals, Drug News, Infectious Disease, Medical News

An analysis published in Open Forum Infectious Diseases found a 56% reduced risk of mortality for COVID-19 patients taking the anti-parasitic drug ivermectin compared to standard of care or another therapy. The study pulled data from 24 randomized trials involving 3,328 patients with moderate to severe COVID-19. The study also found that ivermectin was “associated […]

Australian develops effective Triple Therapy to treat COVID-19

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Infectious Disease, Medical News

‘A combination of FDA and TGA approved Ivermectin, Zinc and Doxycycline has shown positive results for COVID-19 and should be considered immediately to fight the pandemic’ says CDD Medical Director Professor Thomas Borody Australia’s The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody MB, BS, BSc(Med), MD, PhD, DSc, FRACP,FACP,FACG, AGAF, says FDA […]

WHO calls to ramp up dexamethasone production for Covid-19 patients

Categories: coronavirus, COVID-19, Disease Info, Drug Approvals, Drug News, Health & Disease, Health & Fitness, Health News, Industry News, Infectious Disease, Interactive Media, Media, Medical News, Press Release

WHO chief on Monday urged for an increase in production of steroid dexamethasone to treat the critically-ill Covid-19 patients. Taj Pharmaceuticals, the well-known Dexamethasone Tablets API Manufacturer in India gives the assurance of high-quality and purity. The stringent quality-control ensure that every batch of the drug brings a consistent standard.

Dying People Can Access Experimental Drugs for Covid-19, but It’s Complicated

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Health & Disease, Industry News, Infectious Disease, Interactive Media, Medical News

Compassionate use allows very sick people to get access to treatments that might help Covid-19, but it’s not without problems #CoronaVirus #CoronaPrevention #Safety #tajpharmaCorona #CoronaSpread #IndiaFightsCorona #CoronavirusOutbreakindia #CoronavirusPandemic #StaySafeStayHome #IndiaFightsCoronavirus

FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage

Categories: Health News

The FDA has approved an abbreviated new drug application for hydroxychloroquine sulfate tablets to address ongoing shortages of the drug sparked by its still unproven potential as a COVID-19 treatment. The application, submitted by Accord Healthcare, was approved on April 7. The approved indications are uncomplicated malaria due to Plasmodium falciparum, P. malariae, P. ovale, and P. vivax; chronic discoid lupus erythematosus and systemic lupus erythematosus in adults; and acute and chronic rheumatoid arthritis in adults.

Hydroxychloroquine and its effectiveness against COVID-19 treatment

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release

Some politicians and doctors are sparring over whether to use Hydroxychloroquine against the new coronavirus, with many scientists saying the evidence is too thin to recommend it now. The drug Hydroxychloroquine can help tame an overactive immune system. It’s been used since the 1940s to prevent and treat malaria, and to treat rheumatoid arthritis and lupus. It’s sold in generic form and under the brand name Plaquenil in the United States. Doctors also can prescribe it off label for other purposes, as many are doing now for COVID-19.

Coronavirus treatment: Vaccines/drugs in the pipeline for COVID-19

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Health & Disease, Health News, Infectious Disease, Medical News, Press Release

The first COVID-19 vaccine in China is expected to be ready for clinical trials by the end of April, according to Xu Nanping, China’s vice-minister of science and technology. Inovio Pharmaceuticals plans to begin clinical trials on a coronavirus vaccine in April this year.

Letter from Taj Pharma CEO and Leadership Team COVID-19

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Fitness, Industry News, Infectious Disease, Interactive Media, Medical News, Press Release

Dear Colleagues/ Agents / Distributors, The growing outbreak of COVID-19 has affected each one of us in multiple ways, our families, friends, businesses and way of life. This fast-changing situation has forced us to re-evaluate how we operate. At Taj Pharmaceuticals, we are working on using this challenge as an opportunity to make our company […]

Letter from Taj Pharma CEO and Leadership Team on The growing outbreak of COVID-19

Dear Colleagues/ Agents / Distributors, The growing outbreak of COVID-19 has affected each one of us in multiple ways, our families, friends, businesses and way of life. This fast-changing situation has forced us to re-evaluate how we operate. At Taj Pharmaceuticals, we are working on using this challenge as an opportunity to make our company […]

Taj Pharmaceuticals: Our commitment to clients in the spread of COVID-19

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release

We Taj Pharmaceuticals are in the midst of challenging times, brought upon us due to the unimaginable spread of COVID-19. As we grapple with this difficult and ever evolving situation, we wanted to reach out to make sure that you are doing okay and in case you needed any help. It is hard to think of a business that is not impacted by this pandemic, the effects of which we will all continue to feel for a long time. Taj Pharmaceuticals Limited company information | Taj Pharmaceuticals Key Executives | Taj Pharmaceuticals overview | Taj Pharmaceuticals

How to wear a surgical mask correctly

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Drug News, Eating Habits, Health & Disease, Health & Fitness, Health Kiosk, Health News, Healthy Food, Herbal Trends, Industry News, Infectious Disease, Interactive Media, Medical News

With the outbreak of coronavirus infection, people are now being advised to wear surgical masks for protection. Surgical masks are easily available in the market. Experts suggest using surgical masks to protect yourself from harmful airborne bacteria and virus particles, keeping flu at bay. A surgical mask is different from the anti-pollution P-rated or N-rated […]

WHO warning: No evidence that antibody tests can show coronavirus immunity

Categories: Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Health News, Infectious Disease, Interactive Media, Medical News

The WHO said there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. The World Health Organization issued a warning Friday about coronavirus testing, saying there’s no evidence serological tests can show whether a person has immunity or is no longer at risk of becoming reinfected. Bacteria & Viruses, coronavirus, COVID-19, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Medical News, Press Release

Taj Pharmaceuticals started working on mRNA vaccine against coronavirus

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Drug Approvals, Drug News, Health & Disease, Health News, Industry News, Infectious Disease, Interactive Media, Media, Medical News, Press Release

Taj Pharmaceuticals Biotechnological Division has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April.

Center for Transboundary and Emerging Diseases

Categories: Bacteria & Viruses, Disease Info, Disease Trends, Health & Disease, Industry News, Infectious Disease, Medical News, Press Release

Taj Pharmaceuticals organizes response to outbreaks of infectious diseases worldwide through the company’s Center for Transboundary and Emerging Diseases. Taj Pharmaceuticals scientists mobilize resources from across the company and work closely with leaders from government, health organizations, and the veterinary and livestock agricultural communities to identify infectious disease threats early and develop solutions, including vaccines and diagnostic tests, to help rapidly control them.